Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia.

被引：0
|
作者：
Lee, JH [1 ]
Choi, SJ [1 ]
Lee, JH [1 ]
Lee, YS [1 ]
Seol, M [1 ]
Ryu, SG [1 ]
Lee, JS [1 ]
Kim, WK [1 ]
Lee, KH [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：611S / 611S
页数：1
相关论文
共 50 条
  • [1] Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia
    Lee, JH
    Choi, SJ
    Lee, JH
    Lee, YS
    Seol, M
    Ryu, SG
    Jang, S
    Park, CJ
    Chi, HS
    Lee, JS
    Kim, WK
    Lee, KH
    LEUKEMIA RESEARCH, 2006, 30 (02) : 204 - 210
  • [2] Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia
    Lee, Sung-Sook
    Lee, Je-Hwan
    Lee, Jung-Hee
    Kim, Dae-Young
    Kim, Se Hyung
    Lim, Sung-nam
    Lee, Young-Shin
    Seol, Miee
    Ryu, Seong-Gil
    Kang, Young-Ah
    Jang, Seongsoo
    Park, Chan-Jeoung
    Chi, Hyun-Sook
    Yun, Sung-Cheol
    Lee, Kyoo-Hyung
    LEUKEMIA RESEARCH, 2009, 33 (04) : 511 - 517
  • [3] MITOXANTRONE AND INTERMEDIATE-DOSE CYTARABINE IN RELAPSED OR REFRACTORY ACUTE MYELOBLASTIC-LEUKEMIA
    HAROUSSEAU, JL
    MILPIED, N
    BRIERE, J
    DESABLENS, B
    GHANDOUR, C
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1990, 32 (04): : 227 - 230
  • [4] Salvage chemotherapy with mitoxantrone, etoposide, and intermediate-dose cytarabine (MEC) in refractory or relapsed acute leukemia in adults.
    Jang, JH
    Lee, ST
    Hahn, JS
    Ko, YW
    Min, YH
    BLOOD, 2001, 98 (11) : 213B - 213B
  • [5] EFFICACY OF ETOPOSIDE AND MITOXANTRONE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA REFRACTORY TO STANDARD INDUCTION THERAPY AND INTERMEDIATE-DOSE CYTARABINE WITH AMSIDINE
    DAENEN, S
    LOWENBERG, B
    SONNEVELD, P
    VANPUTTEN, WLJ
    VERHOEF, G
    VANVELDHOVEN, M
    HUIJGENS, PC
    LEUKEMIA, 1994, 8 (01) : 6 - 10
  • [6] MITOXANTRONE, ETOPOSIDE, AND INTERMEDIATE-DOSE CYTARABINE - AN EFFECTIVE AND TOLERABLE REGIMEN FOR THE TREATMENT OF REFRACTORY ACUTE MYELOID-LEUKEMIA
    AMADORI, S
    ARCESE, W
    ISACCHI, G
    MELONI, G
    PETTI, MC
    MONARCA, B
    TESTI, AM
    MANDELLI, F
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1210 - 1214
  • [7] Mitoxantrone and Etoposide with or without Intermediate-Dose Cytarabine for the Treatment of Patients with Primary Induction Failure or Relapsed Acute Myeloid Leukemia
    Trifilio, Steven
    Radamaker, Alfred
    Newman, Diane
    Coyle, Kathryn
    Leuer, Katrin Carlson
    Mehta, Jayesh
    Altman, Jessica Kaplan
    Frankfurt, Olga
    Tallman, Martin S.
    BLOOD, 2010, 116 (21) : 897 - 898
  • [8] Combination chemotherapy utilizing continuous infusion of intermediate-dose cytarabine for refractory or recurrent acute myeloid leukemia
    Bahng, H
    Lee, JH
    Ahn, JH
    Lee, JH
    Lee, JS
    Kim, SH
    Kim, WK
    Lee, KH
    LEUKEMIA RESEARCH, 2001, 25 (03) : 213 - 216
  • [9] Infusional etoposide, daunorubicin, vincristine, and cytarabine in relapsed acute myelogenous leukemia.
    Walker, B
    Elkins, S
    Bigelow, C
    Files, J
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S289 - S289
  • [10] Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine -: A pharmacologically based regimen
    Sternberg, DW
    Aird, W
    Neuberg, D
    Thompson, L
    MacNeill, K
    Amrein, P
    Shulman, LN
    CANCER, 2000, 88 (09) : 2037 - 2041
12345